Scientists create fertilizable eggs from skin cells in breakthrough for infertility treatment

In a laboratory in the United States, researchers have accomplished something that has never been done before: they took skin cells from a human being, reprogrammed them into something resembling eggs, and then fertilized those eggs with sperm. The work is preliminary. No babies will result from it. But the implications are being taken seriously by reproductive scientists across the world, who see in this experiment the outline of a solution to one of medicine's most persistent problems: infertility in people who cannot produce viable eggs or sperm of their own.

Infertility affects millions. For many patients, standard treatments like IVF offer no help unless they use donor genetic material—a path that is expensive, emotionally fraught, and not available to everyone. The new research points toward a different possibility: the ability to generate reproductive cells from a patient's own body, using nothing more than a skin cell.

The process begins with a familiar technique called somatic cell nuclear transfer. Scientists take the nucleus—the command center of a cell, where genetic instructions are stored—from a patient's skin cell. They then insert this nucleus into a donor egg that has had its own nucleus removed. The result is a cell that contains the patient's genetic material, but it has a problem: it carries two complete sets of chromosomes instead of one. A normal human egg or sperm contains 23 chromosomes, one half of the 46-chromosome pairs that make up our genome. A cell created through nuclear transfer contains 46 chromosomes—a full double set. If fertilized, the resulting embryo would have too much genetic material to develop properly.

To solve this, the research team developed a new method they call mitomeiosis. It mimics the natural process by which reproductive cells divide and discard one set of chromosomes, leaving behind a cell with the correct genetic load. The researchers created 82 of these egg-like cells, called oocytes. They fertilized them with sperm in the laboratory. Nine percent of the fertilized eggs progressed to the blastocyst stage—the point at which cells begin dividing rapidly, around six days after fertilization. This matches the timeline at which embryos would normally be transferred into the uterus during conventional IVF. The experiment did not proceed beyond this stage.

The finding has generated cautious optimism among reproductive medicine specialists. Ying Cheong, a professor of reproductive medicine at the University of Southampton, called it a proof of concept—the first demonstration that genetic material from ordinary body cells can be placed into an egg, activated, and made to behave like a reproductive cell. He noted that clinicians increasingly encounter patients who cannot use their own eggs, whether because of advancing age or medical conditions. Richard Anderson, a reproductive scientist at the University of Edinburgh, pointed out that many women lose their eggs after cancer treatment. The ability to generate new ones from skin cells would represent a fundamental shift in what medicine can offer.

But the researchers and experts are careful about expectations. This is very early laboratory work. No one has yet shown that an embryo created this way can develop beyond the blastocyst stage, let alone become a healthy pregnancy. Safety questions loom large. The long-term effects of the mitomeiosis process on genetic stability are unknown. The technique would need to be refined, tested extensively in animal models, and subjected to rigorous ethical review before any clinical application could be considered. What the experiment has done is remove one major obstacle from the path: it has shown that the obstacle itself is not insurmountable. The next steps will determine whether this laboratory achievement can eventually become a treatment that changes lives.